Tuberous sclerosis complex-mediated mTORC1 overactivation promotes age-related hearing loss

被引:56
|
作者
Fu, Xiaolong [1 ,2 ]
Sun, Xiaoyang [1 ,2 ]
Zhang, Linqing [1 ,2 ]
Jin, Yecheng [1 ,2 ]
Chai, Renjie [3 ]
Yang, Lili [1 ,2 ]
Zhang, Aizhen [1 ,2 ,4 ]
Liu, Xiangguo [1 ,2 ]
Bai, Xiaochun [5 ]
Li, Jianfeng [4 ]
Wang, Haibo [4 ]
Gao, Jiangang [1 ,2 ]
机构
[1] Shandong Univ, Sch Life Sci, 27 Shanda Nanlu, Jinan 250100, Shandong, Peoples R China
[2] Shandong Univ, Minist Educ Expt Teratol, Key Lab, Jinan, Shandong, Peoples R China
[3] Southeast Univ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China
[4] Shandong Univ, Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250117, Shandong, Peoples R China
[5] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China
来源
JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 128卷 / 11期
关键词
AGING INNER-EAR; OXIDATIVE STRESS; HAIR-CELLS; INDUCED OTOTOXICITY; C57BL/6J MICE; LIFE-SPAN; IN-VIVO; ACTIVATION; RESTRICTION; DISEASE;
D O I
10.1172/JCI98058
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The underlying molecular mechanisms of age-related hearing loss (ARHL) in humans and many strains of mice have not been fully characterized. This common age-related disorder is assumed to be closely associated with oxidative stress. Here, we demonstrate that mTORC1 signaling is highly and specifically activated in the cochlear neurosensory epithelium (NSE) in aging mice, and rapamycin injection prevents ARHL. To further examine the specific role of mTORC1 signaling in ARHL, we generated murine models with NSE-specific deletions of Raptor or Tsc1, regulators of mTORC1 signaling. Raptor-cKO mice developed hearing loss considerably more slowly than WT littermates. Conversely, Tsc1 loss led to the early-onset death of cochlear hair cells and consequently accelerated hearing loss. Tsc1-cKO cochleae showed features of oxidative stress and impaired antioxidant defenses. Treatment with rapamycin and the antioxidant N-acetylcysteine rescued Tsc1-cKO hair cells from injury in vivo. In addition, we identified the peroxisome as the initial signaling organelle involved in the regulation of mTORC1 signaling in cochlear hair cells. In summary, our findings identify overactive mTORC1 signaling as one of the critical causes of ARHL and suggest that reduction of mTORC1 activity in cochlear hair cells may be a potential strategy to prevent ARHL.
引用
收藏
页码:4938 / 4955
页数:18
相关论文
共 50 条
  • [21] mTORC1 underlies age-related muscle fiber damage and loss by inducing oxidative stress and catabolism
    Tang, Huibin
    Inoki, Ken
    Brooks, Susan V.
    Okazawa, Hideki
    Lee, Myung
    Wang, Junying
    Kim, Michael
    Kennedy, Catherine L.
    Macpherson, Peter C. D.
    Ji, Xuhuai
    Van Roekel, Sabrina
    Fraga, Danielle A.
    Wang, Kun
    Zhu, Jinguo
    Wang, Yoyo
    Sharp, Zelton D.
    Miller, Richard A.
    Rando, Thomas A.
    Goldman, Daniel
    Guan, Kun-Liang
    Shrager, Joseph B.
    AGING CELL, 2019, 18 (03)
  • [22] Hyperactive mTORC1 disrupts habenula function and light preference in zebrafish model of Tuberous sclerosis complex
    Doszyn, Olga
    Kedra, Magdalena
    Zmorzynska, Justyna
    ISCIENCE, 2024, 27 (06)
  • [23] MicroRNAs are critical regulators of tuberous sclerosis complex and mTORC1 activity in the size control of the Xenopus kidney
    Romaker, Daniel
    Kumar, Vikash
    Cerqueira, Debora M.
    Cox, Ryan M.
    Wessely, Oliver
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (17) : 6335 - 6340
  • [24] Using tuberous sclerosis complex to understand the impact of MTORC1 signaling on mitochondrial dynamics and mitophagy in neurons
    Ebrahimi-Fakhari, Darius
    Saffari, Afshin
    Wahlster, Lara
    Sahin, Mustafa
    AUTOPHAGY, 2017, 13 (04) : 754 - 756
  • [25] mTORC1 paradoxically drives MiT/TFE activity and lysosomal biogenesis in tuberous sclerosis complex.
    Asrani, Kaushal V.
    Salles, Daniela
    Woo, Juhyung
    Mendes, Adrianna
    Murali, Sanjana
    Vidotto, Thiago
    Argani, Pedram
    Gabrielson, Edward
    Lotan, Tamara
    CANCER RESEARCH, 2021, 81 (13)
  • [26] Long-term use of mTORC1 inhibitors in tuberous sclerosis complex associated neurological aspects
    Moavero, Romina
    Curatolo, Paolo
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (07): : 215 - 225
  • [27] Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus
    Huynh, Hung
    Hao, Huai-Xiang
    Chan, Stephen L.
    Chen, David
    Ong, Richard
    Soo, Khee Chee
    Pochanard, Panisa
    Yang, David
    Ruddy, David
    Liu, Manway
    Derti, Adnan
    Balak, Marissa N.
    Palmer, Michael R.
    Wang, Yan
    Lee, Benjamin H.
    Sellami, Dalila
    Zhu, Andrew X.
    Schlegel, Robert
    Huang, Alan
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (05) : 1224 - 1235
  • [28] PMEL is a predictive biomarker for mTORC1 inhibitor treatment of renal angiomyolipoma in tuberous sclerosis complex patients
    Qiu, Dongxu
    Wang, Zhan
    Wang, Xu
    Wang, Yutao
    Wang, Wenda
    Zhang, Yushi
    HELIYON, 2024, 10 (15)
  • [29] mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development
    H Peng
    J Liu
    Q Sun
    R Chen
    Y Wang
    J Duan
    C Li
    B Li
    Y Jing
    X Chen
    Q Mao
    K-F Xu
    C L Walker
    J Li
    J Wang
    H Zhang
    Oncogene, 2013, 32 : 4702 - 4711
  • [30] mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development
    Peng, H.
    Liu, J.
    Sun, Q.
    Chen, R.
    Wang, Y.
    Duan, J.
    Li, C.
    Li, B.
    Jing, Y.
    Chen, X.
    Mao, Q.
    Xu, K-F
    Walker, C. L.
    Li, J.
    Wang, J.
    Zhang, H.
    ONCOGENE, 2013, 32 (39) : 4702 - 4711